# Songling Xuemaikang in Hypertension and Insomnia Evaluation（SHINE）

> **NCT07709442** · NA · NOT_YET_RECRUITING · sponsor: **Jing Liu** · enrollment: 260 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Songling Xuemaikang Capsule
- **DRUG:** Songling Xuemaikang Capsule Simulant

## Key facts

- **NCT ID:** NCT07709442
- **Lead sponsor:** Jing Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07709442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07709442, "Songling Xuemaikang in Hypertension and Insomnia Evaluation（SHINE）". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07709442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*